In-Depth Insights into the Opioid Use Disorder (OUD) Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Are the Projected Expansion Rates of the Opioid Use Disorder (OUD) Market for the Next Decade?
The opioid use disorder (OUD) market has expanded rapidly in recent years. It is projected to grow from $3.96 billion in 2024 to $4.39 billion in 2025, with a CAGR of 10.9%. The factors that have contributed to its historical growth include increased prescription rates, evolving pain management practices, aggressive drug marketing, and the stigma surrounding addiction.
The opioid use disorder (OUD) market is projected to expand rapidly, reaching $6.94 billion by 2029 with a CAGR of 12.1%. Growth will be driven by regulatory interventions, increased emphasis on alternative pain management strategies, improved treatment accessibility, and the implementation of public health initiatives. Emerging trends will include advancements in treatment technologies, personalized therapy approaches, integrated care models, the rise of community-based support programs, and an emphasis on early intervention and prevention strategies.
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the opioid use disorder (oud) Market?
The increasing number of opioid addiction cases is expected to drive the growth of the opioid use disorder (OUD) market. Opioid addiction results in harmful health effects and can lead to opioid use disorder. The Centers for Disease Control and Prevention reported in March 2024 a rise in synthetic opioid overdoses. This growing addiction crisis is propelling the OUD market.
Request Your Free Opioid Use Disorder (OUD) Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp
Which Companies Are Redefining the Future of the Opioid Use Disorder (OUD) Market?
Major companies operating in the opioid use disorder (OUD) market include:
• Pfizer Inc._x000D_
• Novartis AG_x000D_
• Viatris Inc._x000D_
• Teva Pharmaceutical Industries Ltd._x000D_
• Chiesi Pharmaceuticals S.p.A._x000D_
What Trends Are Poised to Drive the Future Success of the Opioid Use Disorder (OUD) Market?
Product innovation is also gaining popularity in the opioid use disorder (OUD) market. Companies in this market are working on new products to strengthen their position. For example, in May 2023, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for the treatment of moderate to severe OUD. Brixadi is available in two forms: a weekly injection for patients who began treatment with transmucosal buprenorphine or are currently on the medication, and a monthly version for those already receiving it.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
What Are the Main Segments of the Opioid Use Disorder (OUD) Market, and How Are They Evolving?
The opioid use disorder (OUD) market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution
What Are the Leading Regions in the Opioid Use Disorder (OUD) Market Expansion?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Core Features That Define the Opioid Use Disorder (OUD) Market?
Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.
Browse Through More Similar Reports By The Business Research Company:
Oral Thin Films Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report
Used Cars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report
Used Truck Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: